Development of novel preclinical models of secondary resistance to the anti-CD37 antibody drug conjugate (ADC) IMGN529/DEBIO1562 in diffuse large B-cell lymphoma (DLBCL)

被引：1
|
作者：
Arribas, Alberto J. [1 ]
Cascione, Luciano [1 ]
Aresu, Luca [1 ]
Gaudio, Eugenio [1 ]
Rinaldi, Andrea [1 ]
Tarantelli, Chiara [1 ]
Akhmedov, Murodzhon [1 ]
Zucca, Emanuele [2 ]
Rossi, Davide [1 ]
Stathis, Anastasios [2 ]
Bertoni, Francesco [1 ]
机构：
[1] Univ Svizzera Italiana, Oncol Res Inst, Bellinzona, Switzerland
[2] IOSI Oncol Inst Southern Switzerland, Bellinzona, Switzerland
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2853
引用
收藏
页数：2
相关论文
共 46 条
  • [1] Identification of Anti-Lymphoma Biomarkers of Response to the Anti-CD37 Antibody Drug Conjugate (ADC) IMGN529
    Gaudio, Eugenio
    Tarantelli, Chiara
    Arribas, Alberto
    Cascione, Luciano
    Kwee, Ivo
    Rinaldi, Andrea
    Ponzoni, Maurilio
    Bordone, Roberta Pittau
    Stussi, Georg
    Rossi, Davide
    Zucca, Emanuele
    Stathis, Anastasios
    Sloss, Callum
    Bertoni, Francesco
    BLOOD, 2016, 128 (22)
  • [2] IMGN529: A therapeutic maytansinoid conjugate of an anti-CD37 antibody with multiple mechanisms of action for B-cell lymphoma and leukemia
    Deckert, Jutta
    Mayo, Michele F.
    Yi, Yong
    Li, Min
    ChickIas, Sharon
    Tavares, Daniel J.
    Pinkas, Jan
    Chittenden, Thomas D.
    Lutz, Robert J.
    Lambert, John M.
    Park, Peter U.
    CANCER RESEARCH, 2011, 71
  • [3] Antibody and linker selection for the anti-CD37 antibody-maytansinoid conjugate IMGN529 for the treatment of B-cell malignancies
    Park, Peter U.
    Yi, Yong
    Li, Min
    Chicklas, Sharon
    Lai, Katharine C.
    Mayo, Michele F.
    Coccia, Jennifer A.
    Deckert, Jutta
    Pinkas, Jan
    Chittenden, Thomas D.
    CANCER RESEARCH, 2011, 71
  • [4] Preclinical Mechanistic Studies Investigating Neutrophil and Lymphoid Cell Depletion By IMGN529, a CD37-Targeting Antibody-Drug Conjugate (ADC)
    Deckert, Jutta
    Ponte, Jose F.
    Coccia, Jennifer A.
    Lanieri, Leanne
    Chicklas, Sharon
    Yi, Yong
    Watkins, Krystal
    Ruiz-Soto, Rodrigo
    Romanelli, Angela
    Lutz, Robert J.
    BLOOD, 2014, 124 (21)
  • [5] Increased internalization and processing of the CD37-targeting antibody-drug conjugate, naratuximab emtansine (IMGN529), in the presence of rituximab leads to enhanced potency in diffuse large B-cell lymphoma models
    Hicks, Stuart W.
    Lai, Katharine C.
    Yi, Yong
    Shah, Prerak
    Gavrilescu, Cristina L.
    Ponte, Joe
    Sloss, Callum M.
    Romanelli, Angela
    CANCER RESEARCH, 2017, 77
  • [6] IMGN529, a Novel Antibody-Drug Conjugate (ADC) Targeting CD37 Shows Synergistic Activity with Rituximab in Non-Hodgkin Lymphoma (NHL) Models
    Deckert, Jutta
    Sloss, Callum M.
    O'Callaghan, Katie
    Tsui, Jenny
    Dawra, Nemisha
    Yi, Yong
    Coccia, Jennifer A.
    Lanieri, Leanne
    Chicklas, Sharon
    Romanelli, Angela
    BLOOD, 2015, 126 (23)
  • [7] Potent B-Cell Depletion by IMGN529, a CD37-Targeting Antibody-Maytansinoid Conjugate for the Treatment of B-Cell Malignancies
    Deckert, Jutta
    Chicklas, Sharon
    Yi, Yong
    Li, Min
    Pinkas, Jan
    Chittenden, Thomas
    Lutz, Robert J.
    Park, Peter U.
    BLOOD, 2011, 118 (21) : 1591 - 1592
  • [8] IMGN529, a CD37-directed antibody-drug conjugate for the treatment of B-cell malignancies, has a favorable in vitro safety profile
    Deckert, Jutta
    Yi, Yong
    Chicklas, Sharon
    Pinkas, Jan
    Chittenden, Thomas
    Lutz, Robert J.
    Park, Peter U.
    CANCER RESEARCH, 2012, 72
  • [9] A Phase I Study of IMGN529, an Antibody-Drug Conjugate (ADC) Targeting CD37, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
    Stathis, Anastasios
    Freedman, Arnold S.
    Flinn, Ian W.
    Maddocks, Kami J.
    Weitman, Steven
    Berdeja, Jesus G.
    Mejia, Alex V.
    Zucca, Emanuele
    Green, Rebecca
    Romanelli, Angela
    Zildjian, Sybil H.
    Ruiz-Soto, Rodrigo
    Palomba, Lia
    BLOOD, 2014, 124 (21)
  • [10] The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
    Hicks, Stuart W.
    Lai, Katharine C.
    Gavrilescu, L. Cristina
    Yi, Yong
    Sikka, Surina
    Shah, Prerak
    Kelly, Meghan E.
    Lee, Jenny
    Lanieri, Leanne
    Ponte, Jose F.
    Sloss, Callum M.
    Romanelli, Angela
    NEOPLASIA, 2017, 19 (09): : 661 - 671
12345